BGF
UK growth-capital investor backing small and medium-sized businesses across sectors.
Last refreshed: 4 July 2026 · Appears in 1 active topic
Timeline for BGF
Added $14m to Trimtech's seed round and took a board seat
UK Startups and Innovation: J&J backs Trimtech seed to GBP35.6mWhat is BGF?
Who founded BGF?
Why did BGF invest in Trimtech Therapeutics?
Background
BGF joined the board of Trimtech Therapeutics, a Cambridge biotech, adding $14m alongside Johnson & Johnson Innovation (JJDC) as the company's seed round grew to GBP35.6m.
BGF, established in 2011 as the Business Growth Fund by Barclays, HSBC, Lloyds, Royal Bank of Scotland and Standard Chartered in the wake of the financial crisis, is the UK and Ireland's most active growth-capital investor. It takes minority equity stakes of typically GBP3m to GBP30m across sectors from a network of 15 offices, and in 2025 committed to invest more than GBP3bn in UK businesses over five years, including GBP300m earmarked for female-led firms.
The Trimtech board seat extends BGF's reach from its traditional growth-capital, mid-market REMIT into early-stage deep biotech, alongside a large pharmaceutical corporate investor rather than the specialist life-Science venture funds that usually lead such rounds.
